Ikuti
NITISHA SHRIVASTAVA
NITISHA SHRIVASTAVA
Postdoctoral Fellow, Albert Einstein College of Medicine, New York, USA
Email yang diverifikasi di einsteinmed.org
Judul
Dikutip oleh
Dikutip oleh
Tahun
Standard review cold-active microbial lipases: a versatile tool for industrial applications
B Joseph, PW Ramteke, G Thomas, N Shrivastava
Biotechnol Mol Biol Rev 2 (2), 39-48, 2007
1662007
Artificial intelligence in surveillance, diagnosis, drug discovery and vaccine development against COVID-19
G Arora, J Joshi, RS Mandal, N Shrivastava, R Virmani, T Sethi
Pathogens 10 (8), 1048, 2021
892021
Extracellular cold-active lipase of Microbacterium luteolum isolated from Gangotri glacier, western Himalaya: Isolation, partial purification and characterization
B Joseph, N Shrivastava, PW Ramteke
Journal of Genetic Engineering and Biotechnology 10 (1), 137-144, 2012
682012
NR2F1 is a barrier to dissemination of early-stage breast cancer cells
C Rodriguez-Tirado, N Kale, MJ Carlini, N Shrivastava, AA Rodrigues, ...
Cancer research 82 (12), 2313-2326, 2022
242022
Palbociclib renders human papilloma virus–negative head and neck squamous cell carcinoma vulnerable to the senolytic agent navitoclax
NJ Gadsden, CD Fulcher, D Li, N Shrivastava, C Thomas, JE Segall, ...
Molecular Cancer Research 19 (5), 862-873, 2021
222021
Prilocaine hydrochloride protects zebrafish from lethal effects of ionizing radiation: role of hematopoietic cell expansion
M Dimri, J Joshi, N Shrivastava, S Ghosh, R Chakraborti, PK Indracanti
Tokai J Exp Clin Med 40 (1), 8-15, 2015
132015
CDK4/6 Inhibition Induces Senescence and Enhances Radiation Response by Disabling DNA Damage Repair in Oral Cavity Squamous Cell Carcinoma
† Nitisha Shrivastava 1,2 , Claudia Gutierrez Chavez 2, Daniel Li 3, Vikas ...
CANCERS 15 (7), 2023
82023
Establishment of a diverse head and neck squamous cancer cell bank using conditional reprogramming culture methods
D Li, C Thomas, N Shrivastava, A Gersten, N Gadsden, N Schlecht, ...
Journal of medical virology 95 (2), e28388, 2023
82023
Cycloxygenase-2 (COX-2)-a potential target for screening of small molecules as radiation countermeasure agents: an in silico study
J Joshi, T K. Barik, N Shrivastava, M Dimri, S Ghosh, R S. Mandal, ...
Current Computer-Aided Drug Design 9 (1), 35-45, 2013
82013
Epigenetic and pluripotency aspects of disseminated cancer cells during minimal residual disease
MJ Carlini, N Shrivastava, MS Sosa
Biological Mechanisms of Minimal Residual Disease and Systemic Cancer, 1-18, 2018
72018
Cyclooxygenase-2 identified as a potential target for novel radiomodulator scopolamine methyl bromide: An in silico study
N Shrivastava, J Joshi, N Sehgal, IP Kumar
Informatics in Medicine Unlocked 9, 18-25, 2017
52017
Ligand and structure based models for the identification of Beta 2 adrenergic receptor antagonists
J Joshi, M Dimri, S Ghosh, N Shrivastava, R Chakraborti, N Sehgal, J Ray, ...
Current computer-aided drug design 11 (3), 222-236, 2015
42015
Characterization of a Diverse Set of Conditionally Reprogrammed Head and Neck Cancer Cell Cultures
TJ Ow, V Mehta, D Li, C Thomas, N Shrivastava, N Kawachi, AJ Gersten, ...
The Laryngoscope 134 (6), 2748-2756, 2024
12024
CDK4/6 inhibition induces senescence and enhances Radiation Response by disabling DNA damage repair in oral cavity squamous cell carcinoma. Cancers (Basel). 2023; 15
N Shrivastava, CG Chavez, D Li, V Mehta, C Thomas, CD Fulcher, ...
12023
Target based screening of small molecule library identifies pregnelonene, a Nrf2 agonist, as a potential radioprotector in zebrafish
J Joshi, S Ghosh, M Dimri, N Shrivastava, PK Indracanti, J Ray
12014
Scopolamine methylbromide mitigates radiation induced damage and lethality in zebrafish
N Shrivastava, J Joshi, S Ghosh, M Dimri, P Kumar, E Indracanti, ...
12014
Comprehensive functional evaluation of head and neck squamous cell carcinoma with BH3-profiling demonstrates apoptotic competency and therapeutic efficacy of BH3-mimetics
D Li, A Lopez, N Shrivastava, W Chan, C Thomas, R Burk, J Segall, ...
Oral Oncology 159, 107069, 2024
2024
The CDK4/6 inhibitor palbociclib sensitizes oral cavity squamous cell carcinoma to navitoclax-induced apoptosis-An in vitro and in vivo study
N Shrivastava, N Kawachi, MB Prystowsky, E Gavathiotis, C Guha, TJ Ow
Cancer Research 83 (7_Supplement), 5986-5986, 2023
2023
The role of FOXM1 in senescence suppression and radiation resistance in oral cavity squamous cell carcinoma
N Shrivastava, Y Wallach, D Li, C Thomas, MB Prystowsky, I Basu, ...
Cancer Research 82 (12_Supplement), 203-203, 2022
2022
NR2F1 is a barrier to early dissemination of pre-malignant mammary cells
MS Sosa, C Rodriguez-Tirado, N Kale, M Carlini, N Shrivastava, B Khalil, ...
Cancer Research 81 (13_Supplement), 2837-2837, 2021
2021
Sistem tidak dapat melakukan operasi ini. Coba lagi nanti.
Artikel 1–20